Would you consider PMRT in a patient with N0(i+) luminal A disease?  

Does the T stage influence your decision (for example, T1mic)? Would multiple positive nodes showing isolated tumor cells sway your decision? Would a high Oncotype score change you decision?



Answer from: Radiation Oncologist at Community Practice